
Bunge (BG) is anticipated to report a significant decline in its second-quarter earnings, with consensus estimates projecting $1.19 EPS, a 31.2% year-over-year decrease, on sales of $11.4 billion, down 14.2% from the prior year. This expected underperformance is primarily attributed to projected weakness in its Agribusiness and Refined and Specialty Oils segments. The Zacks model does not conclusively predict an earnings beat for BG, which currently holds a Zacks Rank of 3, and the company's shares have already underperformed the industry, declining 29.7% over the past year.
Bunge (BG) is poised for a challenging second quarter, with consensus estimates pointing to significant year-over-year declines in both revenue (-14.2% to $11.4 billion) and earnings per share (-31.2% to $1.19). The primary driver of this anticipated weakness is the core Agribusiness segment, where revenues are expected to fall 19.7% and EBIT is projected to plunge by 32%. Within this segment, the processing business is a key concern, with an expected EBIT drop of 47.5% due to underperformance in North American and European softseeds. Weakness is broad-based, as the Refined and Specialty Oils segment is also forecast to see a 28.2% drop in operating income despite marginal revenue growth, and the Milling segment's operating income is expected to decline 8.2% on higher raw material costs. The company's results will also reflect the divestiture of its Sugar and Bioenergy segment. Reinforcing the negative outlook, the stock has already underperformed its industry by a wide margin over the past year, falling 29.7% versus the industry's 11.5% decline, and a proprietary quantitative model does not predict an earnings beat, with an Earnings ESP of 0.00%.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.70
Ticker Sentiment